Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
NCT00415623 (protocol A0531085)
Age
20–79
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients who had completed the preceding study A0531085, Phase III study, who the investigator judged to be able to further treatment of long term administration in terms of efficacy and safety
Patients who had a treatment compliance rate of at least 80%
You may not be if
The patient who met the discontinuation criteria in the preceding study A0531085
Clareo Health | Long Term Study Of Amlodipine 10mg With Hypertension For Whom Amlodipine 5mg Is Insufficient
